Optimization of Respiratory Effort With Titrated Sedation in AHRF
NCT07679932 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2026-07-01
Summary
Prospective, observational, monocentric study to assess the physiological effects of dexmedetomidine and remifentanil in spontaneously breathing patients with acute hypoxemic respiratory failure receiving high-flow nasal oxygen.
Conditions
- AHRF
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-31
- Primary Completion
- 2028-06-30
- Completion
- 2028-07-31
Countries
- Italy
Study Locations
More Related Trials
-
Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU)
NCT00479661 ·Status: COMPLETED ·Phase: PHASE3
-
Dexmedetomidine-based Sedation in Neurocritical Care Patients
NCT02252523 ·Status: UNKNOWN ·Phase: PHASE2
-
Dexmedetomidine Pharmacokinetics-pharmacodynamics in Mechanically Ventilated Children With Single-organ Respiratory Failure
NCT01076816 ·Status: TERMINATED ·Phase: PHASE3
-
A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation
NCT00216190 ·Status: COMPLETED ·Phase: PHASE4
-
Sedative Effects in Obstructive Sleep Apnea
NCT01733043 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Comparison of Dexmedetomidin and Remifentanil for the Effect on Airway Reflex and Hemodynamic Response During Emergence in Patients Undergoing Craniotomy
NCT01365923 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Stability of Dexmedetomidine Sedation Compared to Propofol Sedation in the Drug Induced Sleep Endoscopy
NCT03892122 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU
NCT00747721 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions
NCT04545242 ·Status: RECRUITING ·Phase: PHASE4
-
Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects
NCT00526760 ·Status: COMPLETED ·Phase: PHASE3
-
Sleep Intervention During Acute Lung Injury
NCT01050699 ·Status: COMPLETED ·Phase: PHASE4
-
Analgesic Depth Evaluation During General Anesthesia With Dexmedetomidine-remifentanil Infusion. A Pilot Study
NCT05785273 ·Status: COMPLETED
-
Effects of Dexmedetomidine on OI, RI and Inflammatory Factors in Patients Undergoing Palatopalatyngoplasty.
NCT03612440 ·Status: UNKNOWN ·Phase: NA
-
A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation
NCT00383890 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19
NCT04499313 ·Status: UNKNOWN ·Phase: PHASE3
-
Dexmedetomidine Infusion and Postoperative Lung Aeration After Thoracic Surgery
NCT06502002 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Dexmedetomidine in Septic Patients
NCT01976754 ·Status: COMPLETED ·Phase: NA
-
The Effect of Dexmedetomidine on Airway Complications After Deep or Awake Extubation
NCT02162433 ·Status: TERMINATED ·Phase: PHASE4
-
Dexmedetomidine for Prolonged Sedation in PICUs
NCT03760978 ·Status: COMPLETED
-
Dexmedetomidine Use for Sedation in Patients Submitted to Tracheal Surgery
NCT03723538 ·Status: COMPLETED
-
Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium
NCT00351299 ·Status: COMPLETED ·Phase: PHASE2
-
Dex as Analgesic Adjuvant in OSA Patients
NCT03613558 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)
NCT00481312 ·Status: COMPLETED ·Phase: PHASE3
-
Dexmedetomidine Versus Propofol for Sedation During Awake Endotracheal Intubation
NCT04753515 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine for Continuous Sedation
NCT00226785 ·Status: TERMINATED ·Phase: PHASE3